Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. ("Novavax" or "the Company") (NASDAQ: NVAX). Investors who purchased ...

How bad is this news for Novavax? Let's find out. Image source: Getty Images.

Trump has suggested that he would elect Kennedy to a position in his administration related to health if he wins the election ...

“The RFK announcement has kind of scrambled some of the traditional thinking [about] a lot of the people that have been ...

The U.S. Food and Drug Administration has asked a federal judge in Texas to throw out a public records lawsuit related to ...

The FDA has extended the expiration date of many ... Ranney suggested. The newly updated COVID-19 vaccine and treatment options like Paxlovid, also remain helpful tools in preventing the ...

NPR reports that the FDA is not including one of the strains of flu — B/Yamagata — in this year's recipe because covid prevention initiatives appear to have pushed it into oblivion. Meanwhile, ...

In a new study examining people with opioid or alcohol use disorder, prescriptions for Ozempic, Wegovy, Mounjaro, and ...

The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.

Standing desks may increase the risk of swollen veins and blood clots, a study in the International Journal of Epidemiology ...

Dow, S&P 500, and Nasdaq futures are rising in premarket trading Thursday as the stock market reacts to Taiwan Semiconductor earnings in light of the recent ASML selloff.